Literature DB >> 17573854

Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours.

L H J Looijenga1, A J M Gillis, H Stoop, R Hersmus, J W Oosterhuis.   

Abstract

The dogma of genome functionality has recently been challenged by identification of non-protein-encoding RNAs, including mi(cro)RNAs. These relatively small sequences interact with mRNA and in the mammalian system, are involved in fine-tuning the process of translation. miRNAs have been found to be of crucial importance for normal development, including stem cell formation. Recent interesting fundamental observations will be discussed in this paper, as well as their impact on the genesis of human germ cell tumours (GCTs), in particular those of the adult testis, seminomas and non-seminomas (type II), and spermatocytic seminomas (type III). miRNA cluster 371-373 is specifically involved in inhibition of cellular senescence induced by oncogenic stress in the type II GCTs. This explains the unusual presence of wild type P53, characteristic of this type of solid cancer. Specific sets of differentiating miRNA were found to characterize the various differentiation lineages within the GCTs, which simulate normal embryonic development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573854     DOI: 10.1111/j.1365-2605.2007.00765.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  21 in total

1.  Cytostatic and cytotoxic properties of Amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes.

Authors:  Barbara Ardelt; Wojciech Ardelt; Piotr Pozarowski; Jan Kunicki; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2007-09-12       Impact factor: 4.534

Review 2.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

Review 3.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.

Authors:  Annika Schaefer; Carsten Stephan; Jonas Busch; George M Yousef; Klaus Jung
Journal:  Nat Rev Urol       Date:  2010-04-06       Impact factor: 14.432

4.  Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.

Authors:  N Fustino; D Rakheja; C S Ateek; J C Neumann; J F Amatruda
Journal:  Int J Androl       Date:  2011-06-22

Review 5.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

Review 6.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

7.  Analysis of microRNA expression in the prepubertal testis.

Authors:  Gregory M Buchold; Cristian Coarfa; Jong Kim; Aleksandar Milosavljevic; Preethi H Gunaratne; Martin M Matzuk
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

8.  In-depth characterization of the microRNA transcriptome in a leukemia progression model.

Authors:  Florian Kuchenbauer; Ryan D Morin; Bob Argiropoulos; Oleh I Petriv; Malachi Griffith; Michael Heuser; Eric Yung; Jessica Piper; Allen Delaney; Anna-Liisa Prabhu; Yongjun Zhao; Helen McDonald; Thomas Zeng; Martin Hirst; Carl L Hansen; Marco A Marra; R Keith Humphries
Journal:  Genome Res       Date:  2008-10-10       Impact factor: 9.043

9.  MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.

Authors:  K-P Dieckmann; M Spiekermann; T Balks; I Flor; T Löning; J Bullerdiek; G Belge
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

10.  Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.

Authors:  Sahra Steinmacher; Sara Y Brucker; Andrina Kölle; Bernhard Krämer; Dorit Schöller; Katharina Rall
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.